 |
Sargramostim |
|---|---|
| Trade Name | Leukine |
| Orphan Indication | Neutropenia associated with bone marrow transplant, for the treatment of graft failure and delay of engraftment, and for the promotion of early engraftment |
| USA Market Approval | USA |
| USA Designation Date | 1990-05-03 00:00:00 |
| Sponsor | Immunex Corporation;51 University Street;Seattle, WA, 98101 |
